Safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate for hyperkalemia management in China: actualize study.
Saved in:
| Title: | Safety, effectiveness and treatment patterns of sodium zirconium cyclosilicate for hyperkalemia management in China: actualize study. |
|---|---|
| Authors: | Shen N; The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China., Zeng X; The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.; Graduate School of Dalian Medical University, Dalian, China., Xie H; Dalian Ruikaer Renal Disease Hospital, Dalian, China., Zhang L; The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, China., Yang J; Hefei First People's Hospital, Hefei, Anhui, China., Lin Y; Wenzhou Integrated Chinese and Western Medicine Hospital, Wenzhou, Zhejiang, China., Liu X; Nanyang Central Hospital, Nanyang, Henan, China., Cai X; Ningbo Traditional Chinese Medicine Hospital, Ningbo, Zhejiang, China., Cao J; Taixing People's Hospital, Taizhou, Jiangsu, China., Zhu Q; Xinghua People's hospital, Xinghua, China., Luo X; Hunan Provincial People's Hospital, Changsha, Hunan, China., Wan X; The First Hospital of Nanjing, Nanjing, Jiangsu, China., Wu H; The First Hospital of Jiaxing, Jiaxing, Zhejiang, China., Ye J; The First People's Hospital of Kunshan, Suzhou, Jiangsu, China., Shan C; Chu Hsien-I Memorial Hospital of Tianjin Medical University, Tianjin, China., Wu Y; Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, Guangdong, China., Cao Y; Handan First Hospital, Handan, China., Lin Y; Linfen Central Hospital, Linfen, Shanxi, China., Yu X; Shanxi Provincial Hospital of Chinese Medicine, Taiyuan, Shanxi, China., Wang H; Liaoning Health Industry Group Bensteel General Hospital, Benxi, Liaoning, China., He J; Nuclear Industry 416 Hospital, Chengdu, Sichuan, China., Tian S; Shiyan People's Hospital, Shiyan, Hubei, China., Wu F; Qidong People's Hospital Affiliated Qidong Hospital of Nantong University, Jiangsu, China., Jiang X; Sandun District of Zhejiang Hospital, Hangzhou, Zhejiang, China., Li L; The First Affiliated Hospital of Xi'an Medical University, Xi'an, Shaanxi, China., Zuo L; Peking University People's Hospital, Beijing, China., Wang Z; Taian City Central Hospital, Tai'an, Shandong, China., Xing C; Jiangsu Province Official Hospital, Nanjing, Jiangsu, China., Yin X; Changshu No.2 People's Hospital, Suzhou, Jiangsu, China., Zhao J; The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia, China., Ma C; Anshan Central Hospital, Anshan, Liaoning, China., Long G; Tianjin People's Hospital, Tianjin, China., Li Q; Tianjin Teda Hospital, Tianjin, China., Hu Y; Clinical Medical College & Affiliated Hospital of Chengdu University, Chengdu, Sichuan, China., Shi Y; AstraZeneca Investment China Co, Medical Affairs, Shanghai, China., Lin H; The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2026 May 14; Vol. 17, pp. 1744687. Date of Electronic Publication: 2026 May 14 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1663-9812 |
|---|---|
| DOI: | 10.3389/fphar.2026.1744687 |
